Literature DB >> 7943039

Pericentromeric genes for non-specific X-linked mental retardation (MRX).

A Gedeon1, B Kerr, J Mulley, G Turner.   

Abstract

Extensive linkage analyses in three families with non-specific X-linked mental retardation (MRX) have localized the gene in each family to the pericentromeric region of the chromosome. The MRX17 gene is localized with a peak lod of 2.41 (theta = 0.0) with the trinucleotide repeat polymorphism at the androgen receptor (AR) gene locus. This gene lies in the interval between the markers DXS255 and DXS990, as defined by recombinants. The MRX18 gene maps to the interval between the markers DXS538 and DXS1126, with a peak lod score of 2.01 (theta = 0.0) at the PFC gene locus. In the third family (Family E) with insufficient informative meioses for assignment of an MRX acronym, the maximum lod score is 1.8 at a recombination fraction of zero for several marker loci between DXS207 and DXS426. Exclusions from the regions of marker loci spanning Xq support the localization of the MRX gene in Family E to the pericentromeric region. Localizations of these and other MRX genes have determined that MRX2 and MRX19 map to distal Xp, MRX3, and MRX6 map to distal Xq, whilst the majority cluster in the pericentromeric region. In addition, we confirm that there are at least two distinct MRX genes near the centromere as delineated by the non-overlapping regional localizations of MRX17 and MRX18. Determination of these non-overlapping localizations is currently the only means of classifying non-syndromal forms of mental retardation and determining the minimum number of MRX loci.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943039     DOI: 10.1002/ajmg.1320510453

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  A novel splicing mutation in the IQSEC2 gene that modulates the phenotype severity in a family with intellectual disability.

Authors:  Irene Madrigal; Maria Isabel Alvarez-Mora; Jordi Rosell; Laia Rodríguez-Revenga; Olof Karlberg; Sascha Sauer; Ann-Christine Syvänen; Montserrat Mila
Journal:  Eur J Hum Genet       Date:  2016-01-06       Impact factor: 4.246

2.  Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly.

Authors:  Michael Field; Patrick S Tarpey; Raffaella Smith; Sarah Edkins; Sarah O'Meara; Claire Stevens; Calli Tofts; Jon Teague; Adam Butler; Ed Dicks; Syd Barthorpe; Gemma Buck; Jennifer Cole; Kristian Gray; Kelly Halliday; Katy Hills; Andrew Jenkinson; David Jones; Andrew Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; David Richardson; Rebecca Shepherd; Alexandra Small; Jennifer Varian; Sofie West; Sara Widaa; Uma Mallya; Richard Wooster; Jenny Moon; Ying Luo; Helen Hughes; Marie Shaw; Kathryn L Friend; Mark Corbett; Gillian Turner; Michael Partington; John Mulley; Martin Bobrow; Charles Schwartz; Roger Stevenson; Jozef Gecz; Michael R Stratton; P Andrew Futreal; F Lucy Raymond
Journal:  Am J Hum Genet       Date:  2007-06-26       Impact factor: 11.025

3.  Chromosomal copy number changes in patients with non-syndromic X linked mental retardation detected by array CGH.

Authors:  D Lugtenberg; A P M de Brouwer; T Kleefstra; A R Oudakker; S G M Frints; C T R M Schrander-Stumpel; J P Fryns; L R Jensen; J Chelly; C Moraine; G Turner; J A Veltman; B C J Hamel; B B A de Vries; H van Bokhoven; H G Yntema
Journal:  J Med Genet       Date:  2005-09-16       Impact factor: 6.318

4.  Localisation of a new gene for non-specific mental retardation to Xq22-q26 (MRX35).

Authors:  X X Gu; R Decorte; P Marynen; J P Fryns; J J Cassiman; P Raeymaekers
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

5.  Expanding the phenotype of IQSEC2 mutations: truncating mutations in severe intellectual disability.

Authors:  Frederic Tran Mau-Them; Marjolaine Willems; Beate Albrecht; Elodie Sanchez; Jacques Puechberty; Sabine Endele; Anouck Schneider; Nathalie Ruiz Pallares; Chantal Missirian; Francois Rivier; Manon Girard; Muriel Holder; Sylvie Manouvrier; Isabelle Touitou; Genevieve Lefort; Pierre Sarda; Anne Moncla; Severine Drunat; Dagmar Wieczorek; David Genevieve
Journal:  Eur J Hum Genet       Date:  2013-05-15       Impact factor: 4.246

6.  Xp11.2 microduplications including IQSEC2, TSPYL2 and KDM5C genes in patients with neurodevelopmental disorders.

Authors:  Ching Moey; Susan J Hinze; Louise Brueton; Jenny Morton; Dominic J McMullan; Benjamin Kamien; Christopher P Barnett; Nicola Brunetti-Pierri; Jillian Nicholl; Jozef Gecz; Cheryl Shoubridge
Journal:  Eur J Hum Genet       Date:  2015-06-10       Impact factor: 4.246

7.  Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation.

Authors:  Guy Froyen; Mark Corbett; Joke Vandewalle; Irma Jarvela; Owen Lawrence; Cliff Meldrum; Marijke Bauters; Karen Govaerts; Lucianne Vandeleur; Hilde Van Esch; Jamel Chelly; Damien Sanlaville; Hans van Bokhoven; Hans-Hilger Ropers; Frederic Laumonnier; Enzo Ranieri; Charles E Schwartz; Fatima Abidi; Patrick S Tarpey; P Andrew Futreal; Annabel Whibley; F Lucy Raymond; Michael R Stratton; Jean-Pierre Fryns; Rodney Scott; Maarit Peippo; Marjatta Sipponen; Michael Partington; David Mowat; Michael Field; Anna Hackett; Peter Marynen; Gillian Turner; Jozef Gécz
Journal:  Am J Hum Genet       Date:  2008-01-24       Impact factor: 11.025

8.  TM4SF10 gene sequencing in XLMR patients identifies common polymorphisms but no disease-associated mutation.

Authors:  Christiane Christophe-Hobertus; Frank Kooy; Jozef Gecz; Marc J Abramowicz; Elke Holinski-Feder; Charles Schwartz; Daniel Christophe
Journal:  BMC Med Genet       Date:  2004-09-02       Impact factor: 2.103

9.  Novel Missense Mutation A789V in IQSEC2 Underlies X-Linked Intellectual Disability in the MRX78 Family.

Authors:  Vera M Kalscheuer; Victoria M James; Miranda L Himelright; Philip Long; Renske Oegema; Corinna Jensen; Melanie Bienek; Hao Hu; Stefan A Haas; Maya Topf; A Jeannette M Hoogeboom; Kirsten Harvey; Randall Walikonis; Robert J Harvey
Journal:  Front Mol Neurosci       Date:  2016-01-11       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.